Company: INSP
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001609550-25-000020
Chunk: 61

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 8
Chunk 61
---
 currency is the U.S. dollar. Our subsidiaries have functional currency in Euro and Yen. The consolidated financial statements are translated to U.S. dollars. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Sales and expenses denominated in foreign currencies are translated at exchange rates in effect on the date of the transaction. Foreign currency transaction gains and losses and the impacts of foreign currency remeasurement are recognized in other (income) expense, net in the consolidated statements of operations and comprehensive income (loss). For the three-month periods ended March 31, 2025 and 2024, we recognized $0.6 million of gain and $0.1 million of loss, net, respectively. Any unrealized gains and losses due to translation adjustments are included in accumulated other comprehensive income within stockholders' equity in the consolidated balance sheets. We had $0.1 million of unrecognized loss and $0.2 million of unrecognized gain in our accumulated other comprehensive income balance as of March 31, 2025 and December 31, 2024, respectively.

9

Table of ContentsInspire Medical Systems, Inc. Notes to Consolidated Financial Statements (unaudited) (Table amounts in thousands, except share and per share amounts)

InvestmentsOur investments are classified as available-for-sale and consisted of the following:March 31, 2025AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term:Commercial paper$13,422 $13 $— $13,435 Corporate debt securities49,630 90 (4)49,716 Certificates of deposit2,994 5 — 2,999 U.S. treasury debt securities249,016 179 (38)249,157 Short-term investments$315,062 $287 $(42)$315,307 Long-Term:Corporate debt securities$25,820 $60 $(13)$25,867 Asset-backed securities158 — — 158 U.S. treasury debt securities18,736 70 — 18,806 Long-term investments$44,714 $130 $(13)$44,831 December 31, 2024AmortizedUnrealized GrossAggregateCostGainsLossesFair ValueShort-Term: